Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alphatec Holdings, Inc.ATEC · Entity 4720 | Director | June 20, 2023 | June 21, 2023 |
| CV Sciences, Inc.CVSI · Entity 8316 | Director | June 02, 2021 | June 03, 2021 |
| Veradigm Inc.MDRX · Entity 13670 | Director | May 31, 2024 | June 20, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alphatec Holdings, Inc.
Report date June 20, 2023 · Filed June 21, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,066 |
Reported balance
After 2023-06-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-06-20 · Grant · Acquired 9,908 · Balance 41,066 F1: On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.
CV Sciences, Inc.
Report date June 02, 2021 · Filed June 03, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.39 · Expires 2031-06-01 | Direct | 275,000 |
Reported balance
After 2021-06-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-02 · Grant · Acquired 275,000 · Balance 275,000 F1: The option is durational-based. All 275,000 option shares vest and become exercisable on April 15, 2022, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service. |
Filing footnotes · ownership attribution and instrument terms
F1: The option is durational-based. All 275,000 option shares vest and become exercisable on April 15, 2022, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.
Veradigm Inc.
Report date May 31, 2024 · Filed June 20, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 77,658 |
Reported balance
After 2024-05-31 transaction · row 1
1 source rowRow 1 · 2024-05-31 · Grant · Acquired 42,106 · Balance 77,658 F1: Award of Restricted Stock Units granted under the Veradigm, Inc. 2024 Stock Incentive Plan on May 31, 2024 (the "Grant Date"). The grant vests 50% on grant Date and the other 50% on the first anniversary of the Grant Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Award of Restricted Stock Units granted under the Veradigm, Inc. 2024 Stock Incentive Plan on May 31, 2024 (the "Grant Date"). The grant vests 50% on grant Date and the other 50% on the first anniversary of the Grant Date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 31, 2024 Filed Jun 20, 2024 21:00 UTC | Veradigm Inc. MDRX · Entity 13670 | GrantCommon Stock | 42,106 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-075700 · ownership.xml · nonDerivative · entry 1 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,658 F1 · kind: Award of Restricted Stock Units granted under the Veradigm, Inc. 2024 Stock Incentive Plan on May 31, 2024 (the "Grant Date"). The grant vests 50% on grant Date and the other 50% on the first anniversary of the Grant Date. Read SEC document |
| June 20, 2023 Filed Jun 21, 2023 23:55 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 9,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-010110 · form4-06212023_110613.xml · nonDerivative · entry 1 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,066 F1 · security: On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 20, 2023, issuer granted to the reporting person 9,908 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 21:08 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | SaleCommon Stock | 9,273 | $16.14 | $149,666.22 |
DisclosureSEC source: 0001415889-23-010058 · form4-06202023_090624.xml · nonDerivative · entry 1 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,158 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 22, 2022, to satisfy certain tax withholding obligations of the reporting person resulting from the vesting of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.89 to $16.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 17, 2022 Filed Aug 17, 2022 22:39 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | SaleCommon Stock | 8,009 | $9.06 | $72,561.54 |
DisclosureSEC source: 0001415889-22-008802 · form4-08172022_030823.xml · nonDerivative · entry 1 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,431 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.93 to $9.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 27, 2022 Filed Jun 28, 2022 20:41 UTC | Veradigm Inc. MDRX · Entity 13670 | GrantCommon Stock | 12,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-039630 · doc4.xml · nonDerivative · entry 1 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,552 F1 · kind: Restricted stock units award with vesting that will occur on the one year anniversary of the grant date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 19:32 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 18,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-003364 · edgar.xml · nonDerivative · entry 1 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,440 F1 · security: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · kind: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · shares: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · price: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On June 15, 2022, issuer granted to the reporting person 18,546 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:31 UTC | Veradigm Inc. MDRX · Entity 13670 | SaleCommon Stock | 6,028 | $16.75 | $100,980.45 |
DisclosureSEC source: 0001209191-22-032834 · doc4.xml · nonDerivative · entry 1 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,796 F1 · price: These transactions were executed in multiple trades at prices ranging from $16.75 to $16.765. The prices reported reflect the weighted average sale price on the transaction date. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 12, 2021 Filed Aug 13, 2021 19:44 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 21,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008171 · edgar.xml · nonDerivative · entry 2 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,894 F2 · security: On August 12, 2021, issuer also granted to the reporting person 21,024 restricted stock units which vest in three equal installments on each of August 12, 2022, August 12, 2023, and August 12, 2024. F3 · security: Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. F2 · shares: On August 12, 2021, issuer also granted to the reporting person 21,024 restricted stock units which vest in three equal installments on each of August 12, 2022, August 12, 2023, and August 12, 2024. F2 · balance_after: On August 12, 2021, issuer also granted to the reporting person 21,024 restricted stock units which vest in three equal installments on each of August 12, 2022, August 12, 2023, and August 12, 2024. Read SEC document |
| August 12, 2021 Filed Aug 13, 2021 19:44 UTC | Alphatec Holdings, Inc. ATEC · Entity 4720 | GrantCommon Stock | 8,870 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008171 · edgar.xml · nonDerivative · entry 1 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,870 F1 · security: On August 12, 2021, issuer granted to the reporting person 8,870 restricted stock units which vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F3 · security: Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. F1 · shares: On August 12, 2021, issuer granted to the reporting person 8,870 restricted stock units which vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. F1 · balance_after: On August 12, 2021, issuer granted to the reporting person 8,870 restricted stock units which vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 20:31 UTC | Veradigm Inc. MDRX · Entity 13670 | SaleCommon Stock | 11,600 | $17.78 | $206,256.12 |
DisclosureSEC source: 0001209191-21-040597 · doc4.xml · nonDerivative · entry 1 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,824 Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 21:01 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantStock Option (right to buy) · Derivative | 275,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001510964-21-000039 · wf-form4_162275405116413.xml · derivative · entry 1 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Underlying: Common Stock · 275,000 shares Expires 2031-06-01 F1 · derivative.exercise_date: The option is durational-based. All 275,000 option shares vest and become exercisable on April 15, 2022, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:37 UTC | Veradigm Inc. MDRX · Entity 13670 | GrantCommon Stock | 12,056 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036252 · doc4.xml · nonDerivative · entry 1 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,424 F1 · kind: Restricted stock units award with vesting that will occur on the one year anniversary of the grant date. Read SEC document |
| June 16, 2020 Filed Jun 19, 2020 00:52 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantCommon Stock · Derivative | 150,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001510964-20-000056 · wf-form4_159252792276096.xml · derivative · entry 1 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2030-06-15 F1 · derivative.exercise_date: The option is durational-based. 150,000 option shares vest and become exercisable on June 16, 2021, provided, however, that there has not been a termination of service as of such date. In no event will the option become exercisable for any additional option shares after a termination of service. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 20:34 UTC | Veradigm Inc. MDRX · Entity 13670 | GrantCommon Stock | 28,368 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034990 · doc4.xml · nonDerivative · entry 1 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,368 F1 · kind: Restricted stock units award with vesting that will occur on the one year anniversary of the grant date. Read SEC document |
| June 20, 2019 Filed Feb 13, 2020 00:35 UTC | CV Sciences, Inc. CVSI · Entity 8316 | PurchaseCommon Stock | 1,181 | $4.24 | $5,005.08 |
DisclosureSEC source: 0001510964-20-000004 · wf-form5_158155408746591.xml · nonDerivative · entry 1 Altman Elizabeth Ann · CIK 0001792340 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,181 F1 · kind: The reporting person owned 1,181 shares of common stock as of October 24, 2019, the date on which the reporting person became a director of CV Sciences, Inc. These shares should have been reported on Form 3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.